Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

Arcus Biosciences Inc

RCUS
10,50
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 11:00:53
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
26/2/202522:35BWArcus Biosciences to Participate in Two Upcoming Investor..
25/2/202522:18EDGAR2Form S-8 - Securities to be offered to employees in employee..
25/2/202522:09EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
25/2/202522:07EDGAR2Form 8-K - Current report
25/2/202522:05BWArcus Biosciences Reports Fourth-Quarter and Full-Year 2024..
24/2/202522:35BWArcus Biosciences Announces New Employment Inducement Grants
19/2/202522:05EDGAR2Form 8-K - Current report
18/2/202522:42EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/2/202512:57BWArcus Biosciences Retains Rights to Casdatifan, a Potential..
18/2/202512:52BWArcus Biosciences, Inc. Announces Underwritten Offering of..
18/2/202512:44EDGAR2Form 8-K - Current report
15/2/202521:45BWNew Data Demonstrated Best-in-Class Potential for..
12/2/202503:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/2/202522:35BWArcus Biosciences Announces New Employment Inducement Grants
10/2/202523:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/2/202523:00BWArcus Biosciences to Present New Data from Casdatifan, a..
06/2/202523:02EDGAR2Form 8-K - Current report
27/1/202522:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/1/202522:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/1/202522:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/1/202522:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202522:35BWArcus Biosciences Announces New Employment Inducement Grants
21/1/202522:11EDGAR2Form 8-K - Current report
21/1/202522:05BWArcus Biosciences Appoints Richard Markus, M.D., Ph.D. as..
24/12/202422:05BWArcus Biosciences Announces New Employment Inducement Grants
20/12/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202422:05BWArcus Biosciences to Participate in the 43rd Annual J.P...
18/12/202402:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202402:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202402:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202422:35BWArcus Biosciences Announces New Employment Inducement Grants
04/12/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/12/202422:35BWArcus Biosciences Announces New Employment Inducement Grants
19/11/202422:05BWArcus Biosciences to Participate in Two Upcoming Investor..
12/11/202422:35BWArcus Biosciences Announces New Employment Inducement Grants
08/11/202423:31EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
06/11/202422:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202422:23EDGAR2Form 8-K - Current report
06/11/202422:22BWArcus Biosciences Reports Third-Quarter 2024 Financial..
05/11/202415:00BWArcus Biosciences Announces that Domvanalimab Plus..
30/10/202414:00BWArcus Biosciences to Present New Data for Anti-TIGIT..
24/10/202422:35BWArcus Biosciences Announces New Employment Inducement Grants
24/10/202422:11EDGAR2Form 8-K - Current report
24/10/202413:30BWFirst Clinical Data for Arcus Biosciences’ HIF-2a Inhibitor,..
22/10/202422:05BWArcus Biosciences to Host Conference Call to Discuss..
09/10/202422:35BWArcus Biosciences Announces New Employment Inducement Grants
09/10/202414:00BWArcus Biosciences to Present First Clinical Data from ARC-20..
02/10/202422:05BWArcus Biosciences Announces Clinical Trial Collaboration..
24/9/202422:35BWArcus Biosciences Announces New Employment Inducement Grants
18/9/202400:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: Min: Max:
Chiusura: 10,50

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network